Yes BBY will be looking at a return on investment.They will be looking at a capital raising with one eye on a much higher NTA.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025